At a glance
- Originator Aventis
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 15 Feb 1995 Discontinued-Preclinical for Alzheimer's disease in Italy (Unknown route)